Franz Fazekas (EAN President Elect; Professor of Neurology and Head, Department of Neurology, Medical University of Graz, Austria) kindly took the time to tell us about EAN’s mission to support and cooperate with national neurological societies, as well as their endeavours to attract more individual members and support neurologists in training regarding both clinical and research aspects.
1. Why is cooperation with national neurologic societies so important for the EAN and how does this happen? What are the benefits for the national neurologic societies? (0:12)
2. Why does the EAN also want to attract more full individual members? (1:50)
3. What benefits does the EAN offer to members? (2:37)
4. How do the EAN provide support to neurologists in training? (3:40)
5. What are the plans of the EAN for coming years? (4:36)
Speaker disclosure: Franz Fazekas has nothing to disclose in relation to this video interview.
Filmed at the 4th Congress of the European Academy of Neurology (EAN), Lisbon, Portugal, June 2018.
Share this Video
Related Videos In Stroke
Hariklia Proios, Stroke Alliance for Europe (SAFE): Presidential Update
The Stroke Alliance for Europe (SAFE) is a non-profit-making organisation that represents a range of patient groups from across Europe. Their mutual goal is to drive stroke prevention up the European political agenda and prevent the incidence of stroke through education. touchNEUROLOGY caught up with the SAFE President, Prof. Hariklia (Harriet) Proios, to discuss the […]
Martin Bretzner, ESOC 2022: Brain-age biomarkers to predict post-stroke recovery
Brain-age biomarkers can be used to predict post-stroke recovery. Dr Martin Bretzner (Lille Neuroscience & Cognition Research Centre, Lille University Hospital, Lille, France) discusses the results of a study using radiomics, an emerging image-quantifying technology to assess ‘brain-age’ biomarkers. The study investigates how relative brain age, rather than chronological age, can enhance stroke surveillance and […]
Miquel Lledós, ESOC 2022: The influence of gut microbiome on ischaemic stroke risk and outcome
The composition of the gut microbiome is a modifiable factor associated with the risk of ischaemic stroke and post-stroke neurological outcome. Dr Miquel Lledós (Stroke Pharmacogenomics and Genetics Laboratory, Sant Pau Research Institute, Barcelona, Spain) discusses the outcome of a study using faecal samples to demonstrate the influence of the gut microbiome on ischaemic stroke […]
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!